Baker Avenue Asset Management
USNA icon

Baker Avenue Asset Management’s Usana Health Sciences USNA Stock Holding History

Baker Avenue Asset Management’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8
Closed -$469 – 1441
2023
Q3 		$469 Hold
8
– – ﹤0.01% 1475
2023
Q2 		$504 Sell
8
-7
-47% -$446 ﹤0.01% 1402
2023
Q1 		$944 Buy
15
+7
+88% +$418 ﹤0.01% 1193
2022
Q4 		$426 Buy
+8
New +$433 ﹤0.01% 1408

Other funds holding USNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Baker Avenue Asset Management's USNA Position: Q4 2023 in Review

Baker Avenue Asset Management sold out of Usana Health Sciences (USNA) in Q4 2023, closing a stake of 8 shares — an estimated $469 sold.

Baker Avenue Asset Management first reported a position in USNA in Q4 2022 and held it in 4 quarters. The position peaked at $944 in Q1 2023. 167 funds tracked by Wall St. Rank hold USNA as of Q4 2023.

  • Baker Avenue Asset Management reported no remaining Usana Health Sciences position as of Q4 2023 after selling out during the quarter.
  • Baker Avenue Asset Management sold 8 Usana Health Sciences shares in Q4 2023, an estimated $469.
  • Baker Avenue Asset Management first reported a position in Usana Health Sciences in Q4 2022 and held it in 4 quarters.
  • Baker Avenue Asset Management's Usana Health Sciences position peaked at $944 in Q1 2023.
  • 167 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2023.

Based on Baker Avenue Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.